European Journal Pharmaceutical and Medical Research
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual GLP-1/GIP agonists have transformed obesity and diabetes care, but rapid weight regain and partial revers
European Journal Pharmaceutical and Medical Research
Breast cancer is a heterogeneous disease with substantial variation in clinical presentation, tumor biology, treatment response, and surgical management. This case series describes
European Journal Pharmaceutical and Medical Research
Breast cancer is a heterogeneous disease with substantial variation in clinical presentation, tumor biology, treatment response, and surgical management. This case series describes
European Journal Pharmaceutical and Medical Research
The progressive loss of muscle mass, strength, and functional ability is the hallmark of skeletal muscular atrophy, a crippling medical condition. Prolonged glucocorticoid therapy,
European Journal Pharmaceutical and Medical Research
Carbon nanotubes (CNTs) have become one of the most versatile classes of nanomaterials in the last three decades, due to their outstanding mechanical strength, tunable electrical c
European Journal Pharmaceutical and Medical Research
Carbon nanotubes (CNTs) have become one of the most versatile classes of nanomaterials in the last three decades, due to their outstanding mechanical strength, tunable electrical c
European Journal Pharmaceutical and Medical Research
The progressive loss of muscle mass, strength, and functional ability is the hallmark of skeletal muscular atrophy, a crippling medical condition. Prolonged glucocorticoid therapy,
European Journal Pharmaceutical and Medical Research
Obesity is a complex, chronic, relapsing condition associated with significant cardiometabolic morbidity, reduced quality of life, and increased healthcare use. Access to comprehen